LP01™ + LPC09 + ST10 (BIFICIST)

Blend
Blend
On this page

Urology

UTI

Functionality

Supports alleviation of cystitis

Inhibits pathogenic E. coli

Dosage / Clinical Study

1) LP01 2.5 billion cells + LPC09 1 billion cells + ST10 1 billion cells + tara gum + cranberry extract + D-mannose

Available Formats

Blend

Finished dosage form

Scientific Support
Clinical studies

1) Vicariotto F. Effectiveness of An Association of a Cranberry Dry Extract, D-Mannose, and the 2 Microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in Women Affected by Cystitis. Journal of Clin Gastroenterol 2014;48:S96-S101. DOI: 10.1097/MCG.0000000000000224

In vitro studies

a) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216.  DOI: 10.35248/2329-8901.20.8.216

b) Mogna L. et al. Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli strains. J. Clin. Gastroenterol. 2012;46 Suppl.S29-32.  Doi: 10.1097/MCG.0b013e31826852b7

c) Amoruso A. et al. A Systematic Evaluation of the Immunomodulatory and Functional Properties of Probiotic Bifidobacterium Breve BR03 (DSM 16604) Lactobacillus plantarum LP01 (LMG P-21021). J Prob Health. 2019;  7:214. Doi: 10.35248/2329-8901.19.7.214

d) Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? (LPC09, LA02, LP01, LRE02, BR03, BL03) J Clin Gastroenterol. 2014; 48 Suppl:S91-95.

Associations